descriptive
Analysis v1
Strong Support
When mice are given liraglutide, the usual dopamine spike caused by nicotine is reduced in the brain’s reward center.
6
0
Evidence from Studies
Supporting (1)
6
Community contributions welcome
6
GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity
Cohort Study
Animal
2023 May 30The study found that when mice were given liraglutide (a diabetes drug), it reduced the brain’s dopamine response to nicotine — meaning the 'reward' feeling from nicotine got weaker.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found